Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1984 Jan;37(1):51–55. doi: 10.1136/jcp.37.1.51

Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue.

R Rossiello, M V Carriero, G G Giordano
PMCID: PMC498617  PMID: 6323544

Abstract

An immunoperoxidase staining technique was used for detecting three major iron binding proteins (ferritin, transferrin and lactoferrin) in 40 breast carcinoma cases and six benign breast proliferative lesions. Ferritin staining was detected mainly in connectival stroma and in histiocytes surrounding neoplastic cells. Few and faint ferritin positivities were also detected in neoplastic cells of 20 carcinoma cases. Transferrin was found inconsistently in myoepithelial cells surrounding normal ductules, or around neoplastic ducts of ductal in situ carcinoma. In eight carcinoma cases, transferrin staining was also positive in neoplastic cells. Lactoferrin was detected only in normal breast epithelial cells and in benign breast proliferative lesions. These immunohistochemical findings may suggest that raised serum ferritin concentrations in breast carcinoma patients might be attributed to stromal reaction rather than to tumour synthesis. Transferrin staining of neoplastic cells in these carcinoma cases appears to be very intriguing, particularly since transferrin is considered an obligate requirement for growing cells, and transferrin receptors have been demonstrated only in dividing cells. On the basis of the immunohistochemical data, lactoferrin might be used as a pointer to benign lesions.

Full text

PDF

Images in this article

52Image
on p.52
52Image
on p.52
52Image
on p.52
52Image
on p.52
52Image
on p.52
53Image
on p.53
53Image
on p.53
53Image
on p.53

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arosio P., Yokota M., Drysdale J. W. Structural and immunological relationships of isoferritins in normal and malignant cells. Cancer Res. 1976 May;36(5):1735–1739. [PubMed] [Google Scholar]
  2. Dörner M. H., Silverstone A., Nishiya K., de Sostoa A., Munn G., de Sousa M. Ferritin synthesis by human T lymphocytes. Science. 1980 Aug 29;209(4460):1019–1021. doi: 10.1126/science.6967622. [DOI] [PubMed] [Google Scholar]
  3. Faulk W. P., Hsi B. L., Stevens P. J. Transferrin and transferrin receptors in carcinoma of the breast. Lancet. 1980 Aug 23;2(8191):390–392. doi: 10.1016/s0140-6736(80)90440-7. [DOI] [PubMed] [Google Scholar]
  4. Hamilton T. A., Wada H. G., Sussman H. H. Identification of transferrin receptors on the surface of human cultured cells. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6406–6410. doi: 10.1073/pnas.76.12.6406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hazard J. T., Drysdale J. W. Ferritinaemia in cancer. Nature. 1977 Feb 24;265(5596):755–756. doi: 10.1038/265755a0. [DOI] [PubMed] [Google Scholar]
  6. Jacobs A., Jones B., Ricketts C., Bulbrook R. D., Wang D. Y. Serum ferritin concentration in early breast cancer. Br J Cancer. 1976 Sep;34(3):286–290. doi: 10.1038/bjc.1976.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jones P. A., Miller F. M., Worwood M., Jacobs A. Ferritinaemia in leukaemia and Hodgkin's disease. Br J Cancer. 1973 Mar;27(3):212–217. doi: 10.1038/bjc.1973.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lamoureux G., Mandeville R., Poisson R., Legault-Poisson S., Jolicoeur R. Biologic markers and breast cancer: a multiparametric study--1. Increased serum protein levels. Cancer. 1982 Feb 1;49(3):502–512. doi: 10.1002/1097-0142(19820201)49:3<502::aid-cncr2820490318>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  9. Marcus D. M., Zinberg N. Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer. J Natl Cancer Inst. 1975 Oct;55(4):791–795. doi: 10.1093/jnci/55.4.791. [DOI] [PubMed] [Google Scholar]
  10. Mason D. Y., Taylor C. R. Distribution of transferrin, ferritin, and lactoferrin in human tissues. J Clin Pathol. 1978 Apr;31(4):316–327. doi: 10.1136/jcp.31.4.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sarcione E. J., Smalley J. R., Lema M. J., Stutzman L. Increased ferritin synthesis and release by Hodgkin's disease peripheral blood lymphocytes. Int J Cancer. 1977 Sep 15;20(3):339–346. doi: 10.1002/ijc.2910200304. [DOI] [PubMed] [Google Scholar]
  12. Shindelman J. E., Ortmeyer A. E., Sussman H. H. Demonstration of the transferrin receptor in human breast cancer tissue. Potential marker for identifying dividing cells. Int J Cancer. 1981 Mar 15;27(3):329–334. doi: 10.1002/ijc.2910270311. [DOI] [PubMed] [Google Scholar]
  13. Summers M., White G., Jacobs A. Ferritin synthesis in lymphocytes, polymorphs and monocytes. Br J Haematol. 1975 Aug;30(4):425–434. doi: 10.1111/j.1365-2141.1975.tb01857.x. [DOI] [PubMed] [Google Scholar]
  14. Taylor C. R. An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin's disease. Eur J Cancer. 1976 Jan;12(1):61–75. doi: 10.1016/0014-2964(76)90125-0. [DOI] [PubMed] [Google Scholar]
  15. Tourville D. R., Ogra S. S., Lippes J., Tomasi T. B., Jr The human female reproductive tract: immunohistological localization of gamma A, gamma G, gamma M, secretory "piece," and lactoferrin. Am J Obstet Gynecol. 1970 Dec 1;108(7):1102–1108. doi: 10.1016/0002-9378(70)90460-6. [DOI] [PubMed] [Google Scholar]
  16. Wahren B., Alpert E., Esposti P. Multiple antigens as marker substances in germinal tumors of the testis. J Natl Cancer Inst. 1977 Mar;58(3):489–498. doi: 10.1093/jnci/58.3.489. [DOI] [PubMed] [Google Scholar]
  17. Weinstein R. E., Bond B. H., Silberberg B. K. Tissue ferritin concentration in carcinoma of the breast. Cancer. 1982 Dec 1;50(11):2406–2409. doi: 10.1002/1097-0142(19821201)50:11<2406::aid-cncr2820501127>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES